Key result
This editorial discusses new data from the REGARDS study on the association of apparent treatment-resistant hypertension with patient characteristics and cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
This editorial discusses new data from the REGARDS study on the association of apparent treatment-resistant hypertension with patient characteristics and cardiovascular outcomes.
T he recent introduction of renal denervation therapy for hypertension has drawn much attention to the problem of resistant hypertension. The frequent failure of medical therapy, as well as expectations that a new era of device-based treatment may be beginning, has encouraged research in this area. It is in this context that Diaz et al 1 provide new data on the association of apparent treatmentresistant hypertension (aTRH) with patient characteristics, as well as outcome (cardiovascular events, all-cause mortality, and cardiovascular mortality), in the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
No takes yet. Share an insight, caveat, or question.
Michael Bursztyn (2014) conducted an editorial in apparent treatment-resistant hypertension (aTRH). apparent treatment-resistant hypertension (aTRH) was evaluated on cardiovascular events, all-cause mortality, and cardiovascular mortality. This editorial discusses new data from the REGARDS study on the association of apparent treatment-resistant hypertension with patient characteristics and cardiovascular outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: